Cargando…

O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer

Ferroptosis is a form of regulated cell death characterized by iron-dependent accumulation of lipid hydroperoxides to lethal levels. YAP has been reported to play a pivotal role in controlling ferroptotic death, and the expression of YAP is enhanced and stabilized by O-GlcNAcylation. However, whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Guoqing, Murshed, Abduh, Li, Haojie, Ma, Ji, Zhen, Ni, Ding, Miao, Zhu, Jiabei, Mao, Siwei, Tang, Xiaochen, Liu, Li, Sun, Fenyong, Jin, Lei, Pan, Qiuhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052337/
https://www.ncbi.nlm.nih.gov/pubmed/33863873
http://dx.doi.org/10.1038/s41420-021-00468-2
_version_ 1783679899128561664
author Zhu, Guoqing
Murshed, Abduh
Li, Haojie
Ma, Ji
Zhen, Ni
Ding, Miao
Zhu, Jiabei
Mao, Siwei
Tang, Xiaochen
Liu, Li
Sun, Fenyong
Jin, Lei
Pan, Qiuhui
author_facet Zhu, Guoqing
Murshed, Abduh
Li, Haojie
Ma, Ji
Zhen, Ni
Ding, Miao
Zhu, Jiabei
Mao, Siwei
Tang, Xiaochen
Liu, Li
Sun, Fenyong
Jin, Lei
Pan, Qiuhui
author_sort Zhu, Guoqing
collection PubMed
description Ferroptosis is a form of regulated cell death characterized by iron-dependent accumulation of lipid hydroperoxides to lethal levels. YAP has been reported to play a pivotal role in controlling ferroptotic death, and the expression of YAP is enhanced and stabilized by O-GlcNAcylation. However, whether O-GlcNAcylation can increase the sensitivity of hepatocellular carcinoma (HCC) cells to ferroptosis remains unknown. In the present study, we found that O-GlcNAcylation increased the sensitivity of HCC cells to ferroptosis via YAP. Moreover, YAP increased the iron concentration in HCC cells through transcriptional elevation of TFRC via its O-GlcNAcylation. With YAP knockdown or YAP-T241 mutation, the increased sensitivity to ferroptosis induced by O-GlcNAcylation was abolished. In addition, the xenograft assay confirmed that O-GlcNAcylation increased ferroptosis sensitivity via TFRC in vivo. In summary, we are the first to find that O-GlcNAcylation can increase ferroptosis sensitivity in HCC cells via YAP/TFRC. Our work will provide a new basis for clinical therapeutic strategies for HCC patients.
format Online
Article
Text
id pubmed-8052337
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80523372021-05-05 O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer Zhu, Guoqing Murshed, Abduh Li, Haojie Ma, Ji Zhen, Ni Ding, Miao Zhu, Jiabei Mao, Siwei Tang, Xiaochen Liu, Li Sun, Fenyong Jin, Lei Pan, Qiuhui Cell Death Discov Article Ferroptosis is a form of regulated cell death characterized by iron-dependent accumulation of lipid hydroperoxides to lethal levels. YAP has been reported to play a pivotal role in controlling ferroptotic death, and the expression of YAP is enhanced and stabilized by O-GlcNAcylation. However, whether O-GlcNAcylation can increase the sensitivity of hepatocellular carcinoma (HCC) cells to ferroptosis remains unknown. In the present study, we found that O-GlcNAcylation increased the sensitivity of HCC cells to ferroptosis via YAP. Moreover, YAP increased the iron concentration in HCC cells through transcriptional elevation of TFRC via its O-GlcNAcylation. With YAP knockdown or YAP-T241 mutation, the increased sensitivity to ferroptosis induced by O-GlcNAcylation was abolished. In addition, the xenograft assay confirmed that O-GlcNAcylation increased ferroptosis sensitivity via TFRC in vivo. In summary, we are the first to find that O-GlcNAcylation can increase ferroptosis sensitivity in HCC cells via YAP/TFRC. Our work will provide a new basis for clinical therapeutic strategies for HCC patients. Nature Publishing Group UK 2021-04-16 /pmc/articles/PMC8052337/ /pubmed/33863873 http://dx.doi.org/10.1038/s41420-021-00468-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zhu, Guoqing
Murshed, Abduh
Li, Haojie
Ma, Ji
Zhen, Ni
Ding, Miao
Zhu, Jiabei
Mao, Siwei
Tang, Xiaochen
Liu, Li
Sun, Fenyong
Jin, Lei
Pan, Qiuhui
O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer
title O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer
title_full O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer
title_fullStr O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer
title_full_unstemmed O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer
title_short O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer
title_sort o-glcnacylation enhances sensitivity to rsl3-induced ferroptosis via the yap/tfrc pathway in liver cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052337/
https://www.ncbi.nlm.nih.gov/pubmed/33863873
http://dx.doi.org/10.1038/s41420-021-00468-2
work_keys_str_mv AT zhuguoqing oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT murshedabduh oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT lihaojie oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT maji oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT zhenni oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT dingmiao oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT zhujiabei oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT maosiwei oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT tangxiaochen oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT liuli oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT sunfenyong oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT jinlei oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer
AT panqiuhui oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer